Details for Patent: 9,289,586

Which drugs does patent 9,289,586 protect, and when does it expire?

Patent 9,289,586 protects AXIRON and is included in one NDA.

This patent has seventeen patent family members in fourteen countries.

Summary for Patent: 9,289,586

Title:	Spreading implement
Abstract:	An implement for applying a volume of liquid to a treatment surface includes a support onto which is mounted a receptacle. The receptacle defines a reservoir space which receives the liquid. The receptacle includes a wall having a working surface that is used to spread the liquid over the treatment surface. The wall is resiliently deformable such that in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement is used in applying a transdermal lotion to the axilla area of a user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same are also provided.
Inventor(s):	Bayly; Peter (Victoria, AU), Bayly; Mark Simon (Victoria, AU), Ahlstrom; Magnus (Victoria, AU), Watkinson; Adam Charles (Somerset, GB)
Assignee:	ACRUX DDS PTY LTD (Victoria, AU)
Application Number:	14/317,412
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,289,586
Patent Claim Types: see list of patent claims	Use; Composition; Device;

Drugs Protected by US Patent 9,289,586

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Eli Lilly And Co	AXIRON	testosterone	SOLUTION, METERED;TRANSDERMAL	022504-001	Nov 23, 2010		DISCN	Yes	No						A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF

International Family Members for US Patent 9,289,586

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2007343579
Brazil	PI0720945
Canada	2674661
China	101636194